This bill provides emergency funding to federally qualified health centers in Maine to help them expand retail pharmacy services in underserved areas. The legislation allocates $699,150 in fiscal year 2026, with $44,250 given to each health center plus an additional $8,850 for each additional site they operate. The funding is intended to support infrastructure that allows these centers to offer prescription drugs more directly to patients when retail pharmacy options are limited. It addresses concerns about reduced pharmacy access in rural areas and conflicting requirements from drug manufacturers under the federal 340B program. The bill takes effect immediately as an emergency measure to preserve public health and safety.
This bill ensures continued funding for Maine's children's residential care facilities by making newly appropriated funds nonlapsing - meaning unspent money carries over to future fiscal years instead of expiring. It directly affects facilities that provide residential care for children and receive reimbursement through MaineCare (the state's Medicaid program), which face potential bed reductions or closures due to funding gaps. The bill removes a requirement for an emergency rate adjustment process for these facilities, streamlining how they receive funding. Key provisions focus on stabilizing financial support to maintain access to critical care services for vulnerable children.
This bill exempts certain over-the-counter (OTC) medicines from Maine's sales tax starting January 1, 2026. It applies to FDA-approved OTC medicines meeting specific labeling requirements, including antacids, contraceptive products, allergy medications, eye/ear/nose treatments, and opioid antagonists. The exemption covers medicines sold directly to consumers without a prescription, but excludes cannabis products. This change affects Maine residents purchasing these specific OTC health products, reducing their out-of-pocket costs for essential medications.
This bill requires the Maine Department of Health and Human Services to amend its rules so that hospitals participating in MaineCare receive at least 75% of the amount they report for costs within 90 days of submitting their cost reports. It directly affects hospitals that submit cost reports for reimbursement under MaineCare, the state's Medicaid program. The change mandates this timeline and reimbursement rate through updates to the MaineCare Benefits Manual (Chapter 101, Chapter III, Section 45) and must be implemented using existing department resources without new state funding.
LD 182 requires Maine's Department of Health and Human Services to set MaineCare reimbursement rates for Maine Veterans' Homes on a per-resident daily basis. This directly affects veterans' facilities (including nursing homes and residential care facilities operated by Maine Veterans' Homes) and ensures MaineCare covers the portion of their operating costs tied to residents receiving MaineCare benefits. The bill mandates annual inflation adjustments to these rates and allows the department to use data from other states or hire third parties to establish them. It does not change eligibility but standardizes how costs for covered residents are calculated and reimbursed.
LD 703 establishes a Maine Health Care Gap Year Program that allocates $500,000 from the General Fund for the 2025-26 fiscal year to incentivize recent college graduates to work in critical health care positions. The program specifically targets underserved and rural communities to address workforce shortages in these areas. It directly affects recent graduates who participate and health care facilities in regions with limited access to services. The initiative provides a structured one-time opportunity for new graduates to gain experience while supporting community health needs.
This Maine bill amends state labor law to prohibit employers from requiring or enforcing noncompete agreements with licensed health care practitioners. The legislation defines a "health care practitioner" as any individual qualified under state law to provide medical services, thereby extending existing protections for low-wage workers and certain veterinarians to this broader group. Additionally, the bill removes a specific exemption that previously allowed noncompete agreements between employers and allopathic or osteopathic physicians to take effect immediately, subjecting them instead to standard waiting periods based on tenure or signing date.
This bill requires health insurance plans in Maine to cover blood testing for perfluoroalkyl and polyfluoroalkyl substances (PFAS) when a healthcare provider deems it medically necessary based on guidelines from the National Academies of Sciences, Engineering, and Medicine. It prohibits insurers from charging deductibles, copays, or coinsurance for these tests. The requirement applies to all health insurance plans issued or renewed in Maine on or after January 1, 2026. The bill states this coverage does not expand the state's essential health benefits under federal law, as it aligns with existing coverage for outpatient lab services.
This resolve authorizes the final adoption of specific regulatory provisions concerning the prescriptive authorities and collaborative relationships for naturopathic doctors in Maine. The Department of Professional and Financial Regulation submitted these rules to the legislature after the standard filing deadline, which required a special legislative action to approve them. By passing this measure, the state legislature grants the necessary approval for these professional practice standards to take effect immediately.
This Maine bill requires hospitals to submit a formal notice to the state department at least 120 days before closing labor and delivery units or changing the level of maternity and newborn care services. The notification must include the effective date, reasons for the change, contact information, and details on how the hospital will handle emergency obstetric care. Hospitals must also document their efforts to notify surrounding facilities within 50 miles, local emergency services, affected patients, and the general public. These provisions are designed to ensure transparency and allow communities adequate time to prepare for changes in essential healthcare services.
